Minimal Residual Disease
About a fifth of children initially cured of acute lymphoblastic leukaemia (ALL), later suffer a relapse due to the persistence of small numbers of cancer cells throughout treatment (‘minimal residual disease’ or MRD). Our research focuses on seeing MRD testing become part of the routine clinical management of all children with ALL
Group Leader Link
https://www.ccia.org.au/about-us/our-people/rosemary-sutton/
Group Leader Name
Dr Rosemary Sutton
Program Link
https://www.ccia.org.au/our-research/improving-diagnosis/minimal-residual-disease-group/
Image
Research Area
Back to top